| Authors: |
Bühler K; Scientific Clinical Centre for Endometriosis, University Hospitals of Saarland, Saarbrücken, Germany; Department of Gynaecology, Jena-University Hospital-Friedrich Schiller University, Jena, Germany. Electronic address: buehler.kf@t-online.de., Roeder C; Pharma Value Consulting, Oberwil, Switzerland. Electronic address: claudia.roeder@external.merckgroup.com., Schwarze JE; Merck Healthcare KGaA, Darmstadt, Germany. Electronic address: juan-enrique.schwarze@merckgroup.com., Lispi M; Merck Healthcare KGaA, Darmstadt, Germany; School of Clinical and Experimental Medicine, Unit of Endocrinology, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: monica.lispi@merckgroup.com., Allignol A; Merck Healthcare KGaA, Darmstadt, Germany. Electronic address: arthur.allignol@gmail.com., Falla E; IQVIA Real World Solutions, London, UK. Electronic address: Edel.Greene@iqvia.com., Lukyanov V; IQVIA Real World Solutions, Amsterdam, Netherlands. Electronic address: vasily.lukyanov@mail.ru., D Hooghe T; Merck Healthcare KGaA, Darmstadt, Germany; Department of Development and Regeneration, Laboratory of Endometrium, Endometriosis, and Reproductive Medicine, KU Leuven, Leuven, Belgium; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University Medical School, New Haven, USA. Electronic address: thomas.dhooghe@merckgroup.com., Fischer R; Gynecological Endocrinology and Reproductive Medicine, Fertility Centre Hamburg, 20095, Hamburg, Germany. Electronic address: robert.fischer@amedes-group.com. |
